Pontifax Venture Capital

London

Firm Location:London • Tel Aviv, Israel • Israel

Investor Firms That Co-Invest with Pontifax Venture Capital

New Enterprise Associates (NEA)Canaan Partners Polaris Partners Foresite Capital RA Capital Pfizer Venture Investments High-Tech Gründerfonds Vida Ventures INKEF Capital Ysios Capital Domain Associates Hbm Partners Kurma Partners Faber Sanofi Ventures Forbion Andera Partners HealthCap EQT Life Sciences

Pontifax Venture Capital Team

Photo of Ohad Hammer, Partner at Pontifax Venture Capital

Pontifax Venture Capital·Partner

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in Israel

Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed)

to see your intro paths to Ohad

Photo of Momi Karako, Partner at Pontifax Venture Capital

Pontifax Venture Capital·Partner

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in Israel

Investors in FinTech (Series B), Investors in Israel (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Series B), Investors in FinTech (Series A)

to see your intro paths to Momi

Photo of Tomer Kariv, Investor at Pontifax Venture Capital

Pontifax Venture Capital·Investor

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in Tel Aviv (Israel)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Tomer

Photo of Silvia Noiman, Venture Partner at Pontifax Venture Capital

Pontifax Venture Capital·Venture Partner

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in Israel

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)

to see your intro paths to Silvia

Photo of Ran Nussbaum, Managing Partner at Pontifax Venture Capital

Pontifax Venture Capital·Managing Partner

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in Israel

Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Seed)

to see your intro paths to Ran

Photo of Iyona Rajkomar, Partner at Pontifax Venture Capital

Pontifax Venture Capital·Partner

Sweet spot: $25.0M

Range: $10.0M - $50.0M

Investors in London

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in London (Other Lists)

to see your intro paths to Iyona